Intelligent Ultrasound Group plc

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022, 2020

In its 2023 reporting, Intelligent Ultrasound Group plc disclosed greenhouse gas emissions of 1.1K tCO2e/year. By scope: Scope 1: 9.9 tCO2e/year; Scope 2: 29.5 tCO2e/year; Scope 3: 1.0K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
1.1K tCO2e/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).9.9 tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.29.5 tCO2e/year
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).1.0K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
20231.1K tCO2e/year
20221.5K tonnes of CO2 (Scope 1 2 and 3)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Generate c.£11m revenue from simulation with growth across all three regions

📅 Medium-term

  • Double Clinical AI revenue to c.£4m
  • SonoLystlive to launch on Voluson Signature 20 and 18
  • Continue to develop ScanNav FetalCheck AI software

🔭 Long-term

  • Develop AI that will enable ultrasound scanning in primary care and ultimately at home to enable ultrasound for all

🌱 ESG Focus Areas

EnvironmentSocial (People and Product)Governance

⚠️ Challenges & Risks +

  • Lower-than-expected sales in Western Europe and China for simulation products
  • Reduction in NHS capital expenditure spending in the UK impacting simulation sales
  • Competition from existing ultrasound manufacturers and well-funded independent AI software vendors in the Clinical AI market
  • Supply chain pressures (though mitigated in the second half of 2023)
  • Potential threats to global, regional and local economies (e.g., geopolitical instability, economic slowdown)

📋 Report Information

Reporting Period: 2023